![Jaime Simon](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Cargos activos de Jaime Simon
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
IGL Pharma, Inc.
![]() IGL Pharma, Inc. Medical/Nursing ServicesHealth Services IGL Pharma, Inc. provides health care services. The company was founded in 2016 by Keith R. Frank and Jamie Simon and is headquartered in Angleton, TX. | Director/Miembro de la Junta | 01/01/2016 | - |
Fundador | 01/01/2016 | - | |
IsoTherapeutics Group LLC
![]() IsoTherapeutics Group LLC BiotechnologyHealth Technology Part of Telix Pharmaceuticals Ltd., IsoTherapeutics Group LLC is a radiopharmaceutical company that offers technologies for developing novel therapeutic and diagnostic agents. The company is based in Angleton, TX. The company was founded in 2005 by Jaime Simon, Keith R. Frank. Keith R. Frank has been the CEO of the company since 2005. IsoTherapeutics Group was acquired by Telix Pharmaceuticals Ltd. on April 09, 2024 for $13.63 million. | Director Técnico/Científico/I+D | 01/01/2005 | - |
Fundador | 01/01/2005 | - |
Historial de carrera de Jaime Simon
Estadísticas
Internacional
Estados Unidos | 3 |
Operativa
Founder | 2 |
Director/Board Member | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Sectorial
Health Services | 2 |
Health Technology | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 2 |
---|---|
IGL Pharma, Inc.
![]() IGL Pharma, Inc. Medical/Nursing ServicesHealth Services IGL Pharma, Inc. provides health care services. The company was founded in 2016 by Keith R. Frank and Jamie Simon and is headquartered in Angleton, TX. | Health Services |
IsoTherapeutics Group LLC
![]() IsoTherapeutics Group LLC BiotechnologyHealth Technology Part of Telix Pharmaceuticals Ltd., IsoTherapeutics Group LLC is a radiopharmaceutical company that offers technologies for developing novel therapeutic and diagnostic agents. The company is based in Angleton, TX. The company was founded in 2005 by Jaime Simon, Keith R. Frank. Keith R. Frank has been the CEO of the company since 2005. IsoTherapeutics Group was acquired by Telix Pharmaceuticals Ltd. on April 09, 2024 for $13.63 million. | Health Technology |
- Bolsa de valores
- Insiders
- Jaime Simon
- Experiencia